Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The acute respiratory distress syndrome
Michael A. Matthay, … , Lorraine B. Ware, Guy A. Zimmerman
Michael A. Matthay, … , Lorraine B. Ware, Guy A. Zimmerman
Published August 1, 2012
Citation Information: J Clin Invest. 2012;122(8):2731-2740. https://doi.org/10.1172/JCI60331.
View: Text | PDF
Review Series

The acute respiratory distress syndrome

  • Text
  • PDF
Abstract

The acute respiratory distress syndrome (ARDS) is an important cause of acute respiratory failure that is often associated with multiple organ failure. Several clinical disorders can precipitate ARDS, including pneumonia, sepsis, aspiration of gastric contents, and major trauma. Physiologically, ARDS is characterized by increased permeability pulmonary edema, severe arterial hypoxemia, and impaired carbon dioxide excretion. Based on both experimental and clinical studies, progress has been made in understanding the mechanisms responsible for the pathogenesis and the resolution of lung injury, including the contribution of environmental and genetic factors. Improved survival has been achieved with the use of lung-protective ventilation. Future progress will depend on developing novel therapeutics that can facilitate and enhance lung repair.

Authors

Michael A. Matthay, Lorraine B. Ware, Guy A. Zimmerman

×

Figure 4

Resolution of ALI requires removal of alveolar edema fluid, removal of the acute inflammatory cells, and repair of the injured alveolar epithelium.

Options: View larger image (or click on image) Download as PowerPoint
Resolution of ALI requires removal of alveolar edema fluid, removal of t...
(A) Alveolar edema fluid reabsorption is driven by vectorial transport of sodium and chloride from the airspaces to the lung interstitium, creating a mini–osmotic gradient. Sodium is transported across apical sodium channels (including epithelial sodium channel [ENaC]) and then extruded basolaterally by sodium-potassium ATPase (NaKATPase). Chloride is transported by transcellular or paracellular pathways. In the presence of endogenous or exogenous cAMP stimulation, the rate of alveolar fluid transport increases substantially, accomplished by increased expression and activity of ENaC, NaKATPase, and opening of the CFTR. For net fluid clearance to occur, however, there needs to be a reasonably intact alveolar epithelial barrier (see C). AQP5, aquaporin 5. (B) The resolution of inflammation in ALI and ARDS requires the removal of neutrophils from the distal airspace of the lung. Neutrophils are normally taken up by alveolar macrophages, a process termed efferocytosis. The rate of neutrophil clearance can be accelerated by regulatory T lymphocytes, in part by release of TGF-β. (C) Restoration of the alveolar epithelial barrier initially occurs by reepithelialization of the epithelial surface by alveolar type II cells. Although it was previously thought that this occurred via proliferation of resident type II cells, new work suggests there may be niches of progenitor cells that also contribute. An α6β4+ progenitor cell has been identified in the mouse lung that is responsible for restoration of the alveolar epithelial barrier after bleomycin-induced lung injury (88). Thus, repair may occur by endogenous stem cell proliferation, not just by epithelial cell migration and proliferation of existing differentiated cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts